| by Yashoda Team | No comments

How Dr. Karuna Jha Delivers Advanced Hematologic Cancer and Transplant Care?

The fight against blood cancer has been revolutionized by cellular medicine. In fact, blood cancer that was considered fatal can now be turned into a story of long-term survival. When drugs fail to work, advanced treatments such as Bone Marrow Transplantation (BMT) and Chimeric Antigen Receptor (CAR) T-cell therapy can give patients a new hope in life. 

Patients seeking world-class treatment should book an appointment with a specialized hematologist and hematologist-oncologist as a first step toward healing. The Hematologist & Hemato-Oncologist in Yashoda Medicity Ghaziabad leads the way in this medical breakthrough, combining advanced technology with passionate, patient-centered care. 

What are Bone Marrow Transplant and CAR-T Therapy?

Bone Marrow Transplant (BMT) and CAR-T therapies are both considered “cell therapies.” However, their mechanisms of action are distinct. BMT, also called stem cell transplantation, is a procedure that replaces a patient’s diseased or damaged bone marrow with healthy stem cells. These stem cells will then “engraft,” meaning they continue producing healthy blood cells, and healthcare becomes a reality.

CAR T therapy is a kind of immunotherapy. It requires taking the patient’s own T cells (immune cells) and genetically modifying them in a laboratory to express a particular “chimeric antigen receptor.” After being infused again, these “enhanced” cells behave like guided missiles, finding and killing the cancer cells that had been “invisible” to the immune system.

How do BMT and CAR-T therapy differ in their approach?

Although both are intended to achieve remission, their methods of operation are totally different. Bone marrow transplant (BMT) is generally employed as a way to raise the dosage of chemotherapy to a much greater extent; the transplant basically “rescues” the body after the marrow has been destroyed. CAR, T is a living drug that grows inside the patient’s body to combat the disease without any intermediaries.

Bone Marrow Transplant (BMT)

  • Primary Goal: Replaces diseased or damaged bone marrow with healthy stem cells.

  • Donor Requirement: Stem cells may come from the patient (autologous) or a donor (allogeneic).

  • Duration of Process: The entire treatment process, including recovery, can take several months.

  • Common Side Effects: May include infections and graft-versus-host disease (GVHD).

  • Hospital Stay: Patients usually require 3–4 weeks of hospitalization for treatment and monitoring.

CAR-T Cell Therapy

  • Primary Goal: Reprograms the patient’s immune system to recognize and attack cancer cells.

  • Donor Requirement: Uses the patient’s own T-cells, which are modified in the laboratory.

  • Duration of Process: The treatment process generally takes a few weeks from cell collection to infusion.

  • Common Side Effects: May include Cytokine Release Syndrome (CRS) and immune-related reactions.

  • Hospital Stay: Patients typically require 1–2 weeks of hospitalization for monitoring and recovery.

Why are these therapies essential for blood cancer patients?

Standard methods such as chemotherapy generally have a tough time with “relapsed” or “refractory” cancer, which means the cancer comes back after the treatment, or it doesn’t respond to the first drugs. BMT remains the primary treatment for a permanent cure in cases of Acute Myeloid Leukemia (AML) and Aplastic Anemia. For certain B-cell lymphomas and Multiple Myeloma, CAR T treatment has come out as a “game changer,” thus giving a chance to the very few who are left with no options to live.

Where can patients find expert Hemato-Oncology care?

Successful outcomes in these complex procedures depend significantly on the clinical team’s expertise, especially the lead surgeon. Dr. Karuna Jha is a well-known hematologist and hematologist-oncologist with more than six years of experience in clinical hematology and bone marrow transplantation.

Her clinical skills cover a very broad spectrum of complicated hematologic conditions, such as:

  • Leukemias: AML, ALL, and Chronic Leukemias.Lymphomas: Both Hodgkin and Non-Hodgkin varieties.
  • Plasma Cell Disorders: Multiple Myeloma.Bone Marrow Failure: Aplastic Anemia and MDS.
  • Hemoglobinopathies: Thalassemia and Sickle Cell Anemia.

Conclusion: Your Partner in Healing at Yashoda Medicity

It is equally important to choose the right center as it is to choose the right treatment. Yashoda Medicity offers a full range of services within one ecosystem for the treatment of blood cancer, including state-of-the-art cell processing labs and specialized BMT units focused on minimizing infection risks. Patients receive a personalized pathway to recovery that not only adheres to the latest global protocols but also offers intensive human support, all under the experienced guidance of doctors like Dr. Karuna Jha.

If you or someone you love is dealing with a complicated blood disorder, do not postpone seeking help until the disease gets worse. Contact the specialists at Yashoda Medicity now and see how remarkable cellular therapies might be the doorway to a brand-new life.